Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Report – Industry Pain, Addiction Drug Efforts Flagging

A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging

Business Investment – Wealth Rules Backed By Science

You don’t want to be the kind of person who doesn’t use the facts to their advantage as it’s a sure-fire way to fail. . . . → Read More: Business Investment – Wealth Rules Backed By Science

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion. . . . → Read More: Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

T-Cell Therapy Company Gains $100M in Venture Funds

A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round. . . . → Read More: T-Cell Therapy Company Gains $100M in Venture Funds

Blood Disorder Drug Maker Acquired in $11.6B Deal

The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal

Three Ways Tech Is Leveling The Playing Field Of Investing

If your idea of people that invest in the stock market is all cigars, pinstripe shirts and suspenders, you need to think again. The reason is new tech in this field means it’s no longer the domain of the filthy rich. . . . → Read More: Three Ways Tech Is Leveling The Playing Field Of Investing

Medical Tech, Phone App Companies Partner on Wound Care

A company making wound care products is collaborating with a developer of mobile apps and analytics to design a more advanced diagnostics system for wounds. . . . → Read More: Medical Tech, Phone App Companies Partner on Wound Care

Investing In The Future Of Technology

Knowing where to put your money is hard, as the changes in this industry are incredibly rapid, and new trends are appearing all the time. . . . → Read More: Investing In The Future Of Technology